Our company

Proton Med was founded as an independent entity, connected to the parent company HealthWatch Swiss, with the aim of meeting the needs of the Serbian drug market. Our goal is to supply the local market with our products in the most efficient, economical and time-saving way, applying unique and customized solutions for each situation. At the same time, we are committed to building strong and long-term relationships with all our partners in the local health sector.

In order to achieve these goals, we have assembled a top team of professionals and implemented the high level of operational standards for which HealthWatch Swiss is known. Although a relatively young company, Proton Med has managed to establish a strong presence on the Serbian pharmaceutical market and is actively working on further expansion of its activities in the near future.

Proton Med was founded in 2013 as a private company with limited liability, specializing in the promotion and sale of medicines on the Serbian market.

We are the exclusive representatives of the Swiss company HealthWatch Swiss, whose mission is the promotion and distribution of the highest quality and most cost-effective therapeutic solutions in the markets of Southeast Europe and beyond.

HealthWatch Swiss is an exclusive partner of several leading manufacturers of pharmaceutical and biotechnology products, including Adalvo, Bluepharma, Genepharm S.A. and Rafarm S.A., companies with a strong global presence and an innovative approach to pharmaceutical product development.

• Adalvo is a pharmaceutical company known for its agility and strategic cooperation with leading global partners. Their business philosophy is based on innovation, efficient product development and smart solutions in the industry. With a presence in more than 140 markets worldwide and partnerships with over 140 commercial partners, Adalvo stands out as a trusted provider of pharmaceutical solutions, winning recognition for exceptional business strategy and ability to adapt to market needs.
  
• .Bluepharma – Indústria Farmacêutica, S.A. is a Portuguese pharmaceutical company based in Coimbra, known for its innovation and global presence. Founded in 2001, Bluepharma has become one of the most entrepreneurial pharmaceutical groups, with a focus on research and development, generic drug manufacturing and contract manufacturing (CDMO). Their commitment to quality was confirmed by US FDA approval, making them the first Portuguese pharmaceutical company to export solid pharmaceutical forms to the US market.
  
• Genepharm S.A. is a renowned Greek pharmaceutical company engaged in the development, production and distribution of generic drugs, providing high-quality and affordable therapeutic solutions in various therapeutic areas.
  
• Rafarm S.A. is one of the leading Greek pharmaceutical companies, specializing in the development and production of complex pharmaceutical products, especially ophthalmic and injectable forms. The company provides development and manufacturing (CDMO), licensing and supply of finished products services, enabling faster drug development and market placement.

Thanks to the strategic cooperation with these globally recognized partners, Proton Med provides high-quality and economical pharmaceutical products on the Serbian market, contributing to the improvement of health care and the availability of therapeutic solutions for patients.